NPRL2 and neoplasm: The percentage of myeloid-derived suppressor cells (MDSC) (Figure 8L) and CD163+ tumor-associated macrophages (TAM) (Figure 8M) were markedly downregulated in tumors expressing NPRL2, whereas the numbers of HLA-DR+ DC cells were significantly increased (Figure 8N).